Clinical Trial Update: Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update on TAG72-CAR T cells for platinum-resistant epithelial ovarian cancer, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• TAG72-CAR T Cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: Platinum-Resistant Ovarian Carcinoma | Phase 1 | Status: RECRUITING